Publikationen in Zusammenarbeit mit Forschern von University of Sheffield (14)

2021

  1. Cost-effectiveness of feedback-informed psychological treatment: Evidence from the IAPT-FIT trial

    Behaviour Research and Therapy, Vol. 142

2020

  1. Estimation of Long-Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX- and Virtual Twin-Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

    JBMR Plus, Vol. 4, Núm. 4

2019

  1. Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women with Hormone Receptor-Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial

    JAMA Oncology, Vol. 5, Núm. 11, pp. 1556-1563

2018

  1. Feedback-informed treatment versus usual psychological treatment for depression and anxiety: a multisite, open-label, cluster randomised controlled trial

    The Lancet Psychiatry, Vol. 5, Núm. 7, pp. 564-572

  2. Nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic Breast cancer: Results from the tnAcity trial

    Annals of Oncology, Vol. 29, Núm. 8, pp. 1763-1770

  3. Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

    Breast, Vol. 41, pp. 133-135

2017

  1. A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject Drugs

    AIDS and Behavior, Vol. 21, Núm. 7, pp. 1791-1811

  2. Advances in the management of HER2-positive early breast cancer

    Critical Reviews in Oncology/Hematology, Vol. 119, pp. 113-122

2016

  1. Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel

    Annals of Oncology, Vol. 27, Núm. 3, pp. 379-390

2015

  1. Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis

    Osteoporosis International, Vol. 26, Núm. 7, pp. 1979-1987

2011

  1. Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

    Osteoporosis International

2009

  1. Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled european study of forsteo (EUROFORS)

    Journal of Bone and Mineral Research, Vol. 24, Núm. 4, pp. 726-736

2008

  1. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 3, pp. 852-860

  2. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment

    Journal of Bone and Mineral Research, Vol. 23, Núm. 10, pp. 1591-1600